Characteristics and outcomes of ventricular tachycardia and premature ventricular contractions ablation in patients with prior mitral valve surgery.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
02 2022
Historique:
revised: 12 10 2021
received: 26 06 2021
accepted: 10 11 2021
pubmed: 16 12 2021
medline: 17 3 2022
entrez: 15 12 2021
Statut: ppublish

Résumé

Data regarding ventricular tachycardia (VT) or premature ventricular complex (PVC) ablation following mitral valve surgery (MVS) is limited. Catheter ablation (CA) can be challenging given perivalvular substrate in the setting of mitral annuloplasty or prosthetic valves. To investigate the characteristics, safety, and outcomes of radiofrequency CA in patients with prior MVS and ventricular arrhythmias (VA). We identified consecutive patients with prior MVS who underwent CA for VT or PVC between January 2013 and December 2018. We investigated the mechanism of arrhythmia, ablation approach, peri-operative complications, and outcomes. In our cohort, 31 patients (77% men, mean age 62.3 ± 10.8 years, left ventricular ejection fraction 39.2 ± 13.9%) with prior MVS underwent CA (16 VT; 15 PVC). Access to the left ventricle was via transseptal approach in 17 patients, and a retrograde aortic approach was used in 13 patients. A combined transseptal and retrograde aortic approach was used in one patient, and a percutaneous epicardial approach was combined with trans-septal approach in one patient. Heterogenous scar regions were present in 94% of VT patients and scar-related reentry was the dominant mechanism of VT. Forty-seven percent of PVC patients had abnormal substrate at the site targeted for ablation. Clinical VA substrates involved the peri-mitral area in six patients with VT and five patients with PVC ablation. No procedure-related complications were reported. The overall recurrence-free rate at 1-year was 72.2%; 67% in the VT group and 78% in the PVC group. No arrhythmia-related death was documented on long-term follow-up. CA of VAs can be performed safely and effectively in patients with MVS.

Sections du résumé

BACKGROUND
Data regarding ventricular tachycardia (VT) or premature ventricular complex (PVC) ablation following mitral valve surgery (MVS) is limited. Catheter ablation (CA) can be challenging given perivalvular substrate in the setting of mitral annuloplasty or prosthetic valves.
OBJECTIVE
To investigate the characteristics, safety, and outcomes of radiofrequency CA in patients with prior MVS and ventricular arrhythmias (VA).
METHODS
We identified consecutive patients with prior MVS who underwent CA for VT or PVC between January 2013 and December 2018. We investigated the mechanism of arrhythmia, ablation approach, peri-operative complications, and outcomes.
RESULTS
In our cohort, 31 patients (77% men, mean age 62.3 ± 10.8 years, left ventricular ejection fraction 39.2 ± 13.9%) with prior MVS underwent CA (16 VT; 15 PVC). Access to the left ventricle was via transseptal approach in 17 patients, and a retrograde aortic approach was used in 13 patients. A combined transseptal and retrograde aortic approach was used in one patient, and a percutaneous epicardial approach was combined with trans-septal approach in one patient. Heterogenous scar regions were present in 94% of VT patients and scar-related reentry was the dominant mechanism of VT. Forty-seven percent of PVC patients had abnormal substrate at the site targeted for ablation. Clinical VA substrates involved the peri-mitral area in six patients with VT and five patients with PVC ablation. No procedure-related complications were reported. The overall recurrence-free rate at 1-year was 72.2%; 67% in the VT group and 78% in the PVC group. No arrhythmia-related death was documented on long-term follow-up.
CONCLUSION
CA of VAs can be performed safely and effectively in patients with MVS.

Identifiants

pubmed: 34911151
doi: 10.1111/jce.15331
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-283

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Kligfield P, Hochreiter C, Niles N, Devereux RB, Borer JS. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. Am J Cardiol. 1987;60(4):397-399.
Delahaye JP, Gare JP, Viguier E, Delahaye F, De Gevigney G, Milon H. Natural history of severe mitral regurgitation. Eur Heart J. 1991;12(suppl. B):5-9.
Hochreiter C, Niles N, Devereux RB, Kligfield P, Borer JS. Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation. 1986;73(5):900-912.
Düren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol. 1988;11(1):42-47.
Boudoulas H, Schaal SF, Stang JM, Fontana ME, Kolibash AJ, Wooley CF. Mitral valve prolapse: cardiac arrest with long-term survival. Int J Cardiol. 1990;26(1):37-44.
Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation. 1985;72(4):753-767.
Narasimhan C, Jazayeri MR, Sra J, et al. Ventricular tachycardia in valvular heart disease. Circulation. 1997;96(12):4307-4313.
Naksuk N, Syed FF, Krittanawong C, et al. The effect of mitral valve surgery on ventricular arrhythmia in patients with bileaflet mitral valve prolapse. Indian Pacing Electrophysiol J. 2016;16(6):187-191.
Vaidya VR, DeSimone CV, Damle N, et al. Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse. J Interv Card Electrophysiol. 2016;46(2):137-143.
Eckart RE, Hruczkowski TW, Tedrow UB, Koplan BA, Epstein LM, Stevenson WG. Sustained ventricular tachycardia associated with corrective valve surgery. Circulation. 2007;116(18):2005-2011.
Narasimhan C, Jazayeri MR, Sra J, et al. Ventricular tachycardia in valvular heart disease: facilitation of sustained bundle-branch reentry by valve surgery. Circulation. 1997;96(12):4307-4313.
Fedgchin B, Pavri BB, Greenspon AJ, Ho RT. Unique self-perpetuating cycle of atrioventricular block and phase IV bundle branch block in a patient with bundle branch reentrant tachycardia. Heart Rhythm. 2004;1(4):493-496.
Lewalter T, Jung W, Preusse CJ, et al. Radiofrequency catheter ablation of an incessant ventricular tachycardia following valve surgery. Pacing Clin Electrophysiol. 2002;25(1):105-108.
Steinberg JS, Gaur A, Sciacca R, Tan E. New-onset sustained ventricular tachycardia after cardiac surgery. Circulation. 1999;99(7):903-908.
Isa Param R, Pérez-Castellano N, Villacastín J, Moreno J, Ruiz E, Solís J. Optimized transseptal approach for left ventricular tachycardia ablation in a patient with a mechanical prosthetic aortic valve. Rev Esp Cardiol. 2005;58(6):756-758.
Liang JJ, Castro SA, Muser D, et al. Electrophysiologic substrate, safety, procedural approaches, and outcomes of catheter ablation for ventricular tachycardia in patients after aortic valve replacement. Clin Electrophysiol. 2019;5(1):28-38.
Kella DK, Sheldon SH, Noheria A, et al. Defining the substrate for ventricular tachycardia ablation: the impact of rhythm at the time of mapping. Indian Pacing Electrophysiol J. 2020;20(4):147-153.
Latchamsetty R, Yokokawa M, Morady F, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. Clin Electrophysiol. 2015;1(3):116-123.
Lukac P, Hjortdal VE, Pedersen AK, Mortensen PT, Jensen HK, Hansen PS. Atrial incision affects the incidence of atrial tachycardia after mitral valve surgery. Ann Thorac Surg. 2006;81(2):509-513.
Mountantonakis S, Frankel DS, Hutchinson MD, et al. Feasibility of catheter ablation of mitral annular flutter in patients with prior mitral valve surgery. Heart Rhythm. 2011;8(6):809-814.
Viles-Gonzalez JF, Enriquez AD, Castillo JG, et al. Incidence, predictors, and evolution of conduction disorders and atrial arrhythmias after contemporary mitral valve repair. Cardiol J. 2014;21(5):569-575.
Yeung-Lai-Wah JA, Qi A, McNeill E, et al. New-onset sustained ventricular tachycardia and fibrillation early after cardiac operations. Ann Thorac Surg. 2004;77(6):2083-2088.
Smith R, Grossman W, Johnson L, Segal H, Collins J, Dalen J. Arrhythmias following cardiac valve replacement. Circulation. 1972;45(5):1018-1023.
Ware JA, Magro SA, Luck JC, et al. Conduction system abnormalities in symptomatic mitral valve prolapse: an electrophysiologic analysis of 60 patients. Am J Cardiol. 1984;53(8):1075-1078.
Marchenese K, Schenk E. Atrioventricular conduction system lesion following cardiac valve replacement. Circulation. 1972;45(suppl. II):188.
Dejgaard LA, Skjølsvik ET, Lie ØH, et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018;72(14):1600-1609.
Perazzolo Marra M, Basso C, De Lazzari M, et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging. 2016;9(8):e005030.
Mizuno H, Vergara P, Maccabelli G, et al. Contact force monitoring for cardiac mapping in patients with ventricular tachycardia. J Cardiovasc Electrophysiol. 2013;24(5):519-524.
Khalil F, Siontis K, Bagameri G, Killu AM. Hybrid catheter-based and surgical techniques for ablation of ventricular arrhythmias. Arrhythm Electrophysiol Rev. 2020;9(2):97-103.
Santangeli P, Shaw GC, Marchlinski FE. Radiofrequency wire facilitated interventricular septal access for catheter ablation of ventricular tachycardia in a patient with aortic and mitral mechanical valves. Circ Arrhythmia Electrophysiol. 2017;10:e004771. https://doi.org/10.1161/CIRCEP.116.004771
Najjar J, Bortone A, Boveda S, Albenque J-P. Radiofrequency ablation of an epicardial ventricular tachycardia through the great cardiac vein in a patient with mitro-aortic mechanical prostheses. EP Europace. 2007;9(11):1069-1072.
Vurgun VK, Altin AT, Kilickap M, Candemir B, Akyurek O. Percutaneous transapical approach and transcatheter closure for ventricular tachycardia ablation. Pacing Clin Electrophysiol. 2018;41(3):334-337.
Santangeli P, Hyman MC, Muser D, Callans DJ, Shivkumar K, Marchlinski FE. Outcomes of percutaneous trans-right atrial access to the left ventricle for catheter ablation of ventricular tachycardia in patients with mechanical aortic and mitral valves. JAMA Cardiology. 2020;6(3):1-6.
Roberts-Thomson KC, Seiler J, Steven D, et al. Percutaneous access of the epicardial space for mapping ventricular and supraventricular arrhythmias in patients with and without prior cardiac surgery. J Cardiovasc Electrophysiol. 2010;21(4):406-411.
Soejima K, Couper G, Cooper JM, Sapp JL, Epstein LM, Stevenson WG. Subxiphoid surgical approach for epicardial catheter-based mapping and ablation in patients with prior cardiac surgery or difficult pericardial access. Circulation. 2004;110(10):1197-1201.
Killu AM, Ebrille E, Asirvatham SJ, et al. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery. Circ Arrhythmia Electrophysiol. 2015;8(1):94-101.
Desimone CV, Hu T, Ebrille E, et al. Catheter ablation related mitral valve injury: the importance of early recognition and rescue mitral valve repair. J Cardiovasc Electrophysiol. 2014;25(9):971-975.
Sheldon SH, Good E. PentaRay entrapment in a mechanical mitral valve during catheter ablation of atrial fibrillation. HeartRhythm Case Rep. 2015;2(2):200-201.
Khairy P, Chauvet P, Lehmann J, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation. 2003;107(15):2045-2050.
Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708):31-40.
Bohnen M, Stevenson WG, Tedrow UB, et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011;8(11):1661-1666.
Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of Catheter Ablation of ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2014;7(4):684-690.
Chung F-P, Lin C-Y, Lin Y-J, et al. Ventricular arrhythmias in nonischemic cardiomyopathy. J Arrhythm. 2018;34(4):336-346.
Shirai Y, Liang JJ, Santangeli P, et al. Comparison of the ventricular tachycardia circuit between patients with ischemic and nonischemic cardiomyopathies. Circ Arrhythmia Electrophysiol. 2019;12(7):e007249.

Auteurs

Fouad Khalil (F)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Takumi Toya (T)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Malini Madhavan (M)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Mohamed Badawy (M)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Ali Ahmad (A)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Suraj Kapa (S)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Siva K Mulpuru (SK)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Konstantinos C Siontis (KC)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Christopher V DeSimone (CV)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Abhishek J Deshmukh (AJ)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Yong-Mei Cha (YM)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Paul A Friedman (PA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Thomas Munger (T)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Samuel J Asirvatham (SJ)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Ammar M Killu (AM)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH